RNA Editing in Pathogenesis of Cancer
- 13 July 2017
- journal article
- review article
- Published by American Association for Cancer Research (AACR) in Cancer Research
- Vol. 77 (14) , 3733-3739
Abstract
Several adenosine or cytidine deaminase enzymes deaminate transcript sequences in a cell type or environment-dependent manner by a programmed process called RNA editing. RNA editing enzymes catalyze A>I or C>U transcript alterations and have the potential to change protein coding sequences. In this brief review, we highlight some recent work that shows aberrant patterns of RNA editing in cancer. Transcriptome sequencing studies reveal increased or decreased global RNA editing levels depending on the tumor type. Altered RNA editing in cancer cells may provide a selective advantage for tumor growth and resistance to apoptosis. RNA editing may promote cancer by dynamically recoding oncogenic genes, regulating oncogenic gene expression by noncoding RNA and miRNA editing, or by transcriptome scale changes in RNA editing levels that may affect innate immune signaling. Although RNA editing markedly increases complexity of the cancer cell transcriptomes, cancer-specific recoding RNA editing events have yet to be discovered. Epitranscriptomic changes by RNA editing in cancer represent a novel mechanism contributing to sequence diversity independently of DNA mutations. Therefore, RNA editing studies should complement genome sequence data to understand the full impact of nucleic acid sequence alterations in cancer. Cancer Res; 77(14); 3733–9. ©2017 AACR.Keywords
All Related Versions
This publication has 50 references indexed in Scilit:
- RNA editing of the GLI1 transcription factor modulates the output of Hedgehog signalingRNA Biology, 2013
- Recoding RNA editing of AZIN1 predisposes to hepatocellular carcinomaNature Medicine, 2013
- Transcriptome-wide sequencing reveals numerous APOBEC1 mRNA-editing targets in transcript 3′ UTRsNature Structural & Molecular Biology, 2011
- RNA editing changes the lesion specificity for the DNA repair enzyme NEIL1Proceedings of the National Academy of Sciences, 2010
- Specificity of ADAR-mediated RNA editing in newly identified targetsRNA, 2008
- Altered adenosine-to-inosine RNA editing in human cancerGenome Research, 2007
- Editing modifies the GABAA receptor subunit 3RNA, 2007
- RNA-editing-mediated exon evolutionGenome Biology, 2007
- Loss of Function of the Candidate Tumor Suppressor prox1 by RNA Mutation in Human Cancer CellsNeoplasia, 2006
- A census of human cancer genesNature Reviews Cancer, 2004